Mofin GP
Mova Pharmaceutical Pvt Ltd
Composition for Mofin GP Products
Mofin GP Products are primarily used for
About Mofin GP Products
Uses of Mofin GP Products
Glibenclamide+Metformin+Pioglitazone is used in the treatment of type 2 diabetes mellitus.
Mofin GP Products side effects
Common
Side Effects of Mofin GP are Hypoglycemia (low blood glucose level), Taste change, Nausea1a, Diarrhea, Stomach pain, Headache, Edema (swelling), Weight gain, Bone fracture, Blurred vision, Respiratory tract infection, Anemia (low number of red blood cells), Vomiting, Flatulence.
How Mofin GP Products work
Glibenclamide + Metformin + Pioglitazone is a combination of three antidiabetic medicines: Glibenclamide + Metformin + Pioglitazone1, Glibenclamide + Metformin + Pioglitazone2 and Glibenclamide + Metformin + Pioglitazone3. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glibenclamide + Metformin + Pioglitazone1 is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Glibenclamide + Metformin + Pioglitazone2 is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Glibenclamide + Metformin + Pioglitazone3 is a thiazolidinedione which further increases insulin sensitivity.
Products for Mofin GP
MRP
₹61.81
Substitute brands for Mofin GP
Glibor MP
Curis Lifecare
1 Product
Diabetrol 3P
Abbott L
2 Products
Tripath
Lupin Ltd
1 Product
Tri Glucodol
Diacardus Pharmacy Pvt Ltd
1 Product
Triformin
East West Pharma
1 Product